US Consumer Prices Rise 38 Annually in April Surpassing Expectations Morgan Stanley Lowers Southern Company Target Cites Potential Utility Sector Underperformance Indian Billionaires Accelerate Overseas Acquisitions Amid Domestic Growth Deceleration Cancer Treatment Costs Soar ACAs Role Under Scrutiny as Expenses Reach Hundreds of Thousands Paul Tudor Jones Says Theres No Chance Warsh Can Secure Fed Rate Cut Market Implications Aluminum Price Surge Strains Major US Companies Cost Mitigation Strategies Emerge Metalla Royalty Streaming Ltd MTA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Stock Rises Slightly Ready Capital Corporation RC Q1 2026 Earnings Massive EPS Miss Sends Shares Lower PTON Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Subscriber Momentum ASO Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Retail Environment FCX Q1 2026 Earnings EPS Surpasses Estimates by 23 Stock Declines Slightly FXNC Q1 2026 Earnings EPS Misses Estimates Slightly Shares Edge Higher GECCH Notes Dip 16 Support Levels and Yield Dynamics in Focus Autolus Therapeutics AUTL Advances 394 as Momentum Builds Toward Key Resistance Kimbell Royalty Partners KRP Holds Steady Near Key Resistance Level Regal Rexnord RRX Slips Amid Broader Market Pressure Key Support Levels in Focus Ranger Energy Services RNGR Posts Modest Gain Consolidating Between Key Levels AMBP Q1 2026 Earnings Strong EPS Beat Amidst Cautious Market Response SPT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable LCID Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction DOC Q1 2026 Earnings EPS Surges 515 Above Estimate as Core Operations Exceed Expectations ROP Q1 2026 Earnings EPS Beat Driven by Operational Strength Amid Modest Market Response VLRS Q1 2026 Earnings EPS Beats Expectations but Stock Slips on Revenue Uncertainty VolitionRx Limited VNRX Highlighted Among TopRated Penny Stocks by Wall Street Analysts EIKN Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage Neumora Therapeutics NMRA Slides 216 as Stock Tests Key Support Levels